Inivata has appointed Emma Green head of clinical development and operations and John Beeler vice president of business development. Green will be responsible for clinical development initiatives at the company's laboratories in Cambridge, UK. Beeler will direct business development-related activities, such as partnerships with diagnostic and pharmaceutical companies and academic institutions internationally.
Green most recently was at Cell Therapy Catapult as head of clinical operations. She previously worked at Pfizer, Aventis, Sosei UK, and Serentis. Beeler was previously the director of theranostics and business development at BioMérieux, where he was responsible for companion diagnostic development and commercialization.